Drugs / serum-derived bovine immunoglobulin protein isolate
serum-derived bovine immunoglobulin protein isolate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01867606 | Oct 2013 → Nov 2015 | female reproductive organ cancer | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | serum-derived bovine immunoglobulin protein isolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01867606 ↗ |
| Modality | Protein / enzyme biologic | “Serum bovine immunoglobulin protein isolate” NCT01867606 ↗ |
| Route | Oral | “Patients receive SBI orally (PO) twice daily (BID) on days 1-28.” NCT01867606 ↗ |